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Traditionally, probiotics have been added to yogurt and other 
fermented foods for health benefits. Currently 56 species of 
Lactobacillus, including L. acidophilus and L. casei and 32 
species of Bifidobacterium, exist. These probiotic cultures are 
able to restore the normal balance of microbial populations 
in the intestine and offer several therapeutic benefits. There 
has been an increasing demand for health-promoting food 
ingredients. Different milks fermented with bacteria, yeasts, 
molds or enzymes offer a broad range of possibilities to cover 
different health aspects with new bioactive components such 
as lactoferrin, micronutrients, CLA, sphingolipids and bioac-
tive peptides or synthesize exo-polysaccharides. In particular, 
milk-proteins and associated bioactive peptides released dur-
ing microbial or enzymatic fermentation of milk offer a broad 
spectrum of new functional properties including anti-hyper-
tensive, anti-microbial, anti-oxidative, and immuno-modula-
tory properties. Gamma-aminobutyric acid (GABA), a non
-protein amino acid, is mainly found in the brain and regulates 
vertebrate physiological and psychological behaviors such as 
anxiety and depression blood pressure and hormone secretion. 
The synthesis of GABA in the brain decreases with age, es-
pecially in elders. Hence, there has been increasing interest 
in use of probiotics for GABA production. In this study, sev-
eral GABA-producing LAB isolates have been isolated from 
naturally fermented foods such as Korean kimchi. Previous 
screening methods are time-consuming and inefficient. In the 
present study, we have developed a novel screening and iden-
tification method for GABA-producing LAB from Korean 
kimchi. Acid treatment was applied to screening procedure 
to obtain acid-tolerant LAB isolates, and then a simple iden-
tification of GABA-producing LAB based on release of gas 
by these bacteria has been developed. The amount of GABA 
produced by LAB isolates at various monosodium gluta-
mate (MSG) concentrations and incubation times in MRS 
medium was quantified by HPLC. Genetic identification of 
high GABA-producing LAB was performed by both 16S 
rRNA gene and glutamate decarboxylase gene. Nine potential 
GABA-producing LAB isolates were selected by observing 
gas release during fermentation. The conversion ability of 
MSG into GABA for all nine LAB isolates was 100% (sup-
plementation level 10 g/L MSG, incubation time 24 h), over 
80% (supplementation level 30 g/L MSG, incubation 48 h), 
over 60% (supplementation level 50 g/L MSG, incubation 
time 72 h) and over 50% (supplementation level 70 g/L MSG, 
incubation time 72 h). These nine LAB isolates were geneti-
cally identified as Lactobacillus brevis by 16S rRNA gene and 
confirmed by glutamate decarboxylase gene.
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The human gastrointestinal tract harbors ten times more mi-
croorganisms than somatic cells in the human body. These 
organisms are part of a diverse and complex ecosystem com-
prising over 3.3 million genes that encode a vast repertoire 
of enzymes and metabolites with the ability to significantly 
influence human health and wellbeing. While a majority of 
these microbes exert health-promoting effects on the host, 
some possess the potential to cause disease. In a healthy state, 
the gut microbiota is known to confer a range of health ben-
efits relating to immune function, nutrition, host metabolism 
and protection against pathogens. Alterations in the normal 
composition of the gut microbiota are associated with an en-
hanced predisposition to immunoinflammatory, autoimmune, 
metabolic and degenerative disorders. Consequently, there has 
been an increasing interest in developing nutrition/diet-based 
strategies for correcting gut microbiota dysbiosis. The use of 
probiotics is one such strategy that has been found to be ef-
fective in restoring perturbed gut microbiota composition and 
function and promoting/restoring optimal health. Amongst 
the many health benefits associated with probiotics, a large 
proportion of research attention over the last two decades 
has focused on their immunomodulatory and anti-infection 
properties. There is evidence that specific probiotics strains 
are effective in preventing and/or managing a range of enteric 
infections and modulating the functioning of the immune sys-
tem. In healthy subjects and subjects with suboptimal immu-
nity, specific strains are able to boost immune function, whilst 
in subjects with dysregulated immune system, such as allergy 
and inflammatory bowel disease, probiotics are effective in 
restoring immune homeostasis and reducing the severity of 
immunoinflammatory disorders. A variety of mechanisms 
by which probiotics mediate their health-enhancing or dis-
ease-preventing effects have been suggested. These include 
direct interaction with the host immune system and through 
the production of diverse array of bioactive molecules/metab-
olites. Dairy-based products are common vehicle for deliver-
ing probiotics. Being a rich source of essential nutrients and 
a variety of biologically active substances with synergistic 
physiological effects, these products offer a significant advan-
